Related Experiment Video
Updated: Feb 18, 2026

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
Glaucoma in patients with shunt-treated normal pressure hydrocephalus
Pasquale Gallina1, Alfonso Savastano2, Eleonora Becattini1
11Department of Surgery and Translational Medicine, Neurosurgery Unit, Tuscany School of Neurosurgery, University of Florence.
Normal tension glaucoma (NTG) is significantly more prevalent in patients with shunted normal pressure hydrocephalus (NPH). Longer exposure to decreased intracranial pressure (ICP) after shunt placement increases NTG risk.
Area of Science:
- Ophthalmology
- Neurosurgery
- Neurology
Background:
- Normal tension glaucoma (NTG) may be linked to pressure gradients at the lamina cribrosa.
- Shunt-treated normal pressure hydrocephalus (NPH) offers a model to study intracranial pressure (ICP) effects on glaucoma.
- Understanding ICP dynamics is crucial for managing NPH and preventing secondary conditions like NTG.
Purpose of the Study:
- To estimate the prevalence of NTG in patients with shunt-treated NPH.
- To assess the relationship between ICP changes (protection and exposure periods) and NTG development.
- To determine if ICP fluctuations are risk factors or protective for glaucoma in NPH patients.
Main Methods:
- Analysis of data from patients who underwent ventriculoperitoneal (VP) shunting for NPH.
- Ophthalmic evaluation for NTG in patients with over 6 months follow-up and no confounding pathologies.
- Calculation of optic nerve exposure to trans-lamina cribrosa pressure gradients.
Main Results:
- NTG prevalence was approximately 40-fold higher in shunt-treated NPH patients compared to the general elderly population (p < 0.001).
- A longer ICP 'protection period' was associated with lower NTG risk (p = 0.033).
- Increased ICP decrease multiplied by exposure duration significantly correlated with NTG development (p = 0.048).
Conclusions:
- The duration of optic nerve exposure to lowered ICP is a critical risk factor for NTG in shunt-treated NPH.
- Informing NPH patients about glaucoma risk prior to CSF shunting is essential.
- Further longitudinal studies are needed to quantify tolerated ICP decrease durations.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

